Comprehensive insights that targeting PIM for cancer therapy: prospects and obstacles

L Chen, W Mao, C Ren, J Li… - Journal of Medicinal …, 2024 - ACS Publications
Proviral integration sitea for Moloney-murine leukemia virus (PIM) kinases are a family of
highly conserved serine/tyrosine kinases consisting of three members, PIM-1, PIM-2, and …

Technologies of targeting histone deacetylase in drug discovery: Current progress and emerging prospects

J Ru, Y Wang, Z Li, J Wang, C Ren, J Zhang - European Journal of …, 2023 - Elsevier
Histone deacetylases (HDACs) catalyze the hydrolysis of acetyl-l-lysine side chains in
histones and non-histones, which are key to epigenetic regulation in humans. Targeting …

GIMAP5 deficiency reveals a mammalian ceramide-driven longevity assurance pathway

AY Park, M Leney-Greene, M Lynberg… - Nature …, 2024 - nature.com
Preserving cells in a functional, non-senescent state is a major goal for extending human
healthspans. Model organisms reveal that longevity and senescence are genetically …

Imidazopyridine-based kinase inhibitors as potential anticancer agents: A review

F Peytam, Z Emamgholipour, A Mousavi, M Moradi… - Bioorganic …, 2023 - Elsevier
Considering the fundamental role of protein kinases in the mechanism of protein
phosphorylation in critical cellular processes, their dysregulation, especially in cancers, has …

Subtype-selective prenylated isoflavonoids disrupt regulatory drivers of MYCN-amplified cancers

ME Stokes, A Vasciaveo, JC Small, A Zask… - Cell Chemical …, 2024 - cell.com
Transcription factors have proven difficult to target with small molecules because they lack
pockets necessary for potent binding. Disruption of protein expression can suppress targets …

Emerging opportunities to treat idiopathic pulmonary fibrosis: Design, discovery, and optimizations of small-molecule drugs targeting fibrogenic pathways

W Luo, Y Gu, S Fu, J Wang, J Zhang, Y Wang - European Journal of …, 2023 - Elsevier
Idiopathic pulmonary fibrosis (IPF) is the most common fibrotic form of idiopathic diffuse lung
disease. Due to limited treatment options, IPF patients suffer from poor survival. About ten …

Synthesis and Anticancer Activity of Novel Dual Inhibitors of Human Protein Kinases CK2 and PIM-1

P Wińska, M Wielechowska, M Koronkiewicz… - Pharmaceutics, 2023 - mdpi.com
CK2 and PIM-1 are serine/threonine kinases involved in the regulation of many essential
processes, such as proliferation, differentiation, and apoptosis. Inhibition of CK2 and PIM-1 …

Casein kinase 2 (CK2): A possible therapeutic target in acute myeloid leukemia

Ø Bruserud, H Reikvam - Cancers, 2023 - mdpi.com
Simple Summary Acute myeloid leukemia (AML) is an aggressive blood cancer disease that
can only be cured by intensive anticancer treatment, and for several patients, allogeneic …

Strategies of targeting CYP51 for IFIs therapy: Emerging prospects, opportunities and challenges

R Zhang, Y Wang, A Wu, J Wang, J Zhang - European Journal of Medicinal …, 2023 - Elsevier
CYP51, a monooxygenase associated with the sterol synthesis pathway, is responsible for
the catalysis of the 14-methyl hydroxylation reaction of lanosterol precursors. This enzyme is …

Discovery of a CK2α′-Biased ATP-Competitive Inhibitor from a High-Throughput Screen of an Allosteric-Inhibitor-Like Compound Library

D Mudaliar, RH Mansky, A White… - ACS Chemical …, 2024 - ACS Publications
Protein kinase CK2 is a holoenzyme composed of two regulatory subunits (CK2β) and two
catalytic subunits (CK2α and CK2α′). CK2 controls several cellular processes, including …